Delivery Order 36F79721D0141-36C24526N0532
Award Date 4/22/26
Potential Completion Date 4/23/26
Potential Value $27K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Veterans Integrated Service Network 5 issued a $41,172.06 delivery order to Recordati Rare Diseases Inc. on May 4, 2026, for Signifor 40mg medication to be delivered to the Washington DC VA Medical Center Pharmacy, with ultimate completion by May 8, 2026. The order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Place of performance is Bartlett, TN 38134. The order is firm fixed price with no set-aside designation. Recordati Rare Diseases Inc. is a...
- The Department of Veterans Affairs Veterans Health Administration awarded a $10,868 delivery order against Recordati Rare Diseases, Inc.'s Pharmaceuticals and Drugs GSA Schedule to supply SIGNIFOR LAR 40 MG. The prime contractor will deliver the drug to a facility in Bartlett, Tennessee within the period of performance from October 11-13, 2023. Recordati Rare Diseases, Inc. will perform as the prime contractor under this firm fixed price contract issued by VA-VHA Network 5 to support its...
- The Department of Veterans Affairs Veterans Health Administration awarded a $10,868 delivery order against Recordati Rare Diseases, Inc.'s Pharmaceuticals and Drugs GSA Schedule to supply SIGNIFOR LAR 40 MG. The prime contractor, Recordati Rare Diseases Inc. Division, will deliver the pharmaceutical to the VA Veterans Integrated Service Network 5 location in Bartlett, Tennessee between December 7-11, 2023. The firm fixed price order is funded by the VA-VHA to support its provision of...
- Recordati Rare Diseases Inc. received a $11,241.96 firm fixed-price delivery order from Veterans Integrated Service Network 5 (VISN 5) for Signifor LAR 20 mg, a specialized pharmaceutical treatment for rare endocrine disorders such as Cushing's disease and acromegaly. The award, issued on September 5, 2025, with an ultimate completion date of September 9, 2025, represents a small but critical procurement to support veteran healthcare services in the Bartlett, Tennessee area. This delivery...
- Recordati Rare Diseases Inc. was awarded a delivery order against its Pharmaceuticals and Drugs Federal Supply Schedule contract to provide Signifor LAR 30 mg and 40 mg to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The potential value of this firm fixed price order is $21,623.35 to be performed at a place of performance in Bartlett, Tennessee by January 31, 2024. Recordati holds two key indefinite-delivery vehicles for supplying...
- The Department of Veterans Affairs Veterans Health Administration awarded a $10,793.52 delivery order against Recordati Rare Diseases, Inc.'s Pharmaceuticals and Drugs GSA Schedule contract to supply SIGNIFOR LAR 30 MG. The prime contractor, Recordati Rare Diseases Inc., will deliver the specified pharmaceutical to the VA facility located in Bartlett, Tennessee. The order has a period of performance from December 27, 2023 through December 29, 2023 and utilizes a firm fixed price contract type....
- This is a $43,266.00 delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Recordati Rare Diseases Inc. to provide SIGNIFOR LAR 30 MG AND 40 MG pharmaceuticals. The contract is issued against Recordati's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is a firm fixed price delivery order with a completion date of April 16, 2024. No set-aside designation was used. Recordati Rare Diseases Inc. is a foreign-owned, for-profit...
- This is a firm fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Recordati Rare Diseases Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $22,438.42, is for the supply of Signifor LAR 40 mg, an orphan drug used to treat rare medical conditions. The contract was awarded under the VA's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs, and has an ultimate completion date of April 8, 2025. The...
- The U.S. Department of Veterans Affairs (VA) awarded a delivery order contract to Recordati Rare Diseases Inc., a division of the international pharmaceutical company Recordati Group, for the provision of Signifor LAR 40 mg. The order, valued at $10,811.24, is being delivered under Recordati's Federal Supply Schedule (FSS-61-IB) contract with the VA, a five-year, $15.6 million indefinite-delivery vehicle established in April 2021. The contract does not include a set-aside designation, reflecting...
- The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price delivery order contract to Recordati Rare Diseases Inc., a division of the Recordati Group, for the pharmaceutical product Signifor LAR 40 mg. The contract has a ceiling value of $10,811.24 and an ultimate completion date of November 22, 2024. This delivery order is placed against Recordati's five-year, $15.6 million Federal Supply Schedule (FSS-61-IB) contract with the VA, which allows for the procurement of the company's...